Could a common steroid save lives in severe sepsis and lung injury?
NCT ID NCT07511582
First seen Apr 18, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study tests whether the steroid methylprednisolone can improve organ function and reduce deaths in critically ill patients with sepsis or acute respiratory distress syndrome (ARDS) who have a hyperinflammatory condition. About 150 adults will receive either a high or low dose of the drug or a placebo for up to 7 days. Researchers will monitor organ function and survival for 30 days to see if the treatment helps control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.